molecular

    • Contrast
    • Layout
    • Font

Market Research

Surveys
Nullam sed velit neque. Integer tincidunt dui quis augue pulvinar.
Personal interviews
Nullam sed velit neque. Integer tincidunt dui quis augue pulvinar.
Task analysis
Morbi sapien turpis, ultricies sed laoreet vel, fermentum nec.
Read more

Recent Posts

    Recent Comments

    No comments to show.
    OVER 90,000 PEOPLE IN EUROPE DEVELOP MELANOMA EACH YEAR. MELANOMA IS A MALIGNANT NEOPLASM OF THE SKIN. IT IS CHARACTERIZED BY A DYNAMIC GROWTH THAT GIVES METASTASES, WHICH IS WHY EARLY DETECTION IS SO IMPORTANT.

    BEST FEATURES

    MOBILE APPLICATION FOR PATIENTS
    MOBILE APPLICATION AND THE AR APPLICATION FOR DOCTORS AND CLINICS
    3D BODY MAP
    CLOUD MODULE FOR PROCESSING IMAGES AND MAKING ANALYZES
    LOCATE

    Point moles on 3D body map
    capture icon
    CAPTURE

    Take photos with Molecular
    compare-icon
    COMPARE

    Compare and make analyzes
    BE REMINDED

    Get reminders

    SCREENSHOTS

    Thanks to the Molecular solution, you do not have to wait in a long line or go to a dermatologist right away. You can easily add and monitor your moles on a 3D model. Take a photo of the skin lesion with your smartphone! Thanks to artificial intelligence, you will be able to quickly process images and analyze them.

    The Molecular platform is designed to support the process of archiving and verification of photos of patients' birthmarks so that the prevention of melanoma becomes more accessible.

    DOCTORS AND CLINICS

    THE ABILITY TO CREATE A DOCTOR'S ACCOUNT
    MAKING APPOINTMENTS

    CREATING A LIST OF PATIENTS
    THE POSSIBILITY OF BUILDING A MEDICAL HISTORY

    Contact Us

    CEO

    PERFORMING SKIN CHECKS REGULARLY HELPS YOU DETECT SKIN CANCER SIGNS IN THE EARLY STAGE AND KEEP ON TOP OF SKIN CANCER.

    HOW TO PROPERLY EXAMINE MOLES AND BIRTHMARKS USING THE ABCDE METHOD?

    LET’S TALK!


    MOLECULAR
    Małgorzata Gulewicz
    +48 600 173 584
    malgorzata.gulewicz@owliot.eu
    www.owliot.eu

      Back to top